Prostaglandin E1: Electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease

American Journal of Therapeutics

Volumn 4, Issue 11-12, 1997, Pages 401-404

  Somberg, John C ^a,b   Yelamanchi, V ^a   Molnar, Janos ^a   Aschermann, Michael ^c   Bernink, P J L M ^c   Caspi, Avi ^c   Marmor, Alon ^c   Rabinowitz, Babeth ^c   Reisin, Leonardo ^c   Ruzyllo, Witold ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b FUHS The Chicago Medical School   (United States)

^c NONE

Author keywords

Peripheral arterial occlusive disease; Proarrhythmia; Prostaglandin E1

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; PROSTAGLANDIN E1;

ARRHYTHMOGENESIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ARTICLE; CHEMICALLY INDUCED DISORDER; CONGESTIVE HEART FAILURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; PATHOPHYSIOLOGY;

ALPROSTADIL; ARRHYTHMIA; ARTERIAL OCCLUSIVE DISEASES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PERIPHERAL VASCULAR DISEASES;

EID: 0031260853     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199711000-00010     Document Type: Conference Paper

References (20)

1. 1 in heart disease: review and perspective. Am J Ther 1997;4:353-358.
2. Karetova D, Bultas J, Vondracek V, Aschermann M: Alprostadil: modes of action in peripheral arterial occlusive disease. Am J Ther 1997;4:359-364.
3. Bayer BL, Forster W: On a direct, anti-adrenergic component of prostaglandin action in the heart. Acta Biol Med Ger 1978;37:829-830.
4. 1 for the treatment of peripheral arterial occlusive disease in patients with congestive heart failure. Am J Ther 1997;4:365-374.
5. Cardiac Arrhythmia Suppression Trial II Investigators: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-233.
6. 2 on the sympathetically stimulated rabbit heart. Acta Physiol Scand 1971;83:156-168.
7. 2 on the neuromuscular transmission in the guinea pig vas deferens. Acta Physiol Scand 1969; 77:510-518.
8. 2 on ouabain cardiotoxicity in the cat. J Pharmacol Exp Ther 1977;203:480-484.
9. Cagin N, Freeman E, Somberg J, et al: A comparison of the in vivo and in vitro actions of ouabain to produce cardiac arrhythmias. Arch Int Pharmacodyn Ther 1974; 207:162-169.
10. Gillis R, Pearle D, Levitt B. Digitalis: a neuro-excitatory drug. Circulation 1975;52:739-742.
11. Levitt B, Cagin N, Somberg J, Bounous H, Mittag T, Raines A: Alteration of the effects and distribution of ouabain by spinal cord transection in the cat. J Pharmacol Exp Ther 1973;185:24-28.
12. Roberts J, Levitt B, Standaert F: A possible role of the autonomic nervous system in the control of cardiac rhythm. Nature 1967;214:915.
13. Levitt B, Raines A, Sohn YJ, Standaert F, Hirshfeld J: The nervous system as a site of action for digitalis and antiarrhythmic drugs. Mt Sinai J Med 1970;37:227-340.
14. 1 and cardiac arrhythmia. Eur J Pharmacol 1972;18:392-395.
15. 2 on ventricular arrhythmias during myocardial infarction in conscious dogs: relation to infarct size. Prostagland Med 1981;7: 431-455.
16. 1: a review. Med Klin 1992;87:123-130.
17. Mann D: Action of prostaglandins on heart arrhythmias. Acta Biol Med Ger 1976;35:1113-1117.
18. 2 antiarrhythmic properties. Am Heart J 1981;102:123-124.
19. Bayer BL, Forster W, Sperling X: Beeinflussung Von Leitungsgeschwindigkeit und Refraktarperide des Herzens in vitro und in vitro duch Prostoglandine. J Arch Int Pharmacodyn 1976;221:328-338.
20. Kerin NZ, Somberg J: Proarrhythmia: definition, risk factors, causes, treatment and controversies. Am Heart J 1994;128:575-585.